Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Looking for novel ways to treat the hallmarks of Alzheimer's disease.

Stewart AJ, Fox A, Morimoto BH, Gozes I.

Expert Opin Investig Drugs. 2007 Aug;16(8):1183-96. Review.

PMID:
17685868
2.

Therapeutic targets for Alzheimer's disease.

Tarditi A, Caricasole A, Terstappen G.

Expert Opin Ther Targets. 2009 May;13(5):551-67. doi: 10.1517/14728220902865614 . Review.

PMID:
19368497
3.

Disease modifying approaches for Alzheimer's pathology.

Sadowski M, Wisniewski T.

Curr Pharm Des. 2007;13(19):1943-54. Review.

PMID:
17627527
4.
5.

Can lithium or valproate untie tangles in Alzheimer's disease?

Tariot PN, Aisen PS.

J Clin Psychiatry. 2009 Jun;70(6):919-21. No abstract available.

PMID:
19573485
6.

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

Swerdlow RH.

Neurobiol Aging. 2007 Oct;28(10):1465-80. Epub 2006 Jul 31. Review.

PMID:
16876913
7.

Isoprenoids and Alzheimer's disease: a complex relationship.

Cole SL, Vassar R.

Neurobiol Dis. 2006 May;22(2):209-22. Epub 2006 Jan 10. Review.

PMID:
16406223
8.

Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease.

Münch G, Gasic-Milenkovic J, Arendt T.

J Neural Transm Suppl. 2003;(65):63-71. Review.

PMID:
12946049
9.

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Siegel GJ, Chauhan NB, Feinstein DL, Li G, Larson EB, Breitner JC, Montine TJ.

Neurology. 2008 Jul 29;71(5):383; author reply 383. doi: 10.1212/01.wnl.0000324089.63164.16. No abstract available.

PMID:
18663190
10.

Neuropathologic changes in Alzheimer's disease.

Wenk GL.

J Clin Psychiatry. 2003;64 Suppl 9:7-10. Review.

11.

Images in pathology: Alzheimer's disease.

Jay V.

J Insur Med. 2002;34(2):127-30. Review.

PMID:
15305790
12.
13.

Alzheimer's disease.

Yaari R, Corey-Bloom J.

Semin Neurol. 2007 Feb;27(1):32-41. Review.

PMID:
17226739
14.

Neuropathologic changes in Alzheimer's disease: potential targets for treatment.

Wenk GL.

J Clin Psychiatry. 2006;67 Suppl 3:3-7; quiz 23. Review.

15.

Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Silbert LC.

Neurology. 2007 Aug 28;69(9):E8-11. No abstract available.

PMID:
17724280
16.

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

Mesulam MM.

Neuron. 1999 Nov;24(3):521-9. Review. No abstract available.

18.

So what if tangles precede plaques?

Price JL, Morris JC.

Neurobiol Aging. 2004 Jul;25(6):721-3; discussion 743-6. Review. No abstract available.

PMID:
15165694
19.

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.

Pei JJ, Sjögren M, Winblad B.

Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b. Review.

PMID:
18852562
20.

Tangles precede plaques but don't cause them.

Terry RD.

Neurobiol Aging. 2004 Jul;25(6):741-2; discussion 743-6. No abstract available.

PMID:
15165697

Supplemental Content

Support Center